ARTICLE | Clinical News
BufferGel: Phase II/IIb data
February 16, 2009 8:00 AM UTC
ReProtect Inc., Baltimore, Md. Product: BufferGel Business: Infectious Molecular target: NA Description: Microbicidal spermicide Indication: Prevent infection of women by HIV and other sexually trans...